| Date Filed | Type | Description |
| 11/15/2018 |
SC 13G
| Pharmstandard International S.A. reports a 4.2% stake in Allena Pharmaceuticals, Inc. |
| 11/15/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/20/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G
| Pharmstandard International S.A. reports a 5% stake in Allena Pharmaceuticals, Inc. |
| 02/14/2018 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/02/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/02/2017 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Disposed of 99,495 shares
@ $795.96, valued at
$79.2M
|
|
| 08/16/2017 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
| 08/15/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 06/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/23/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/11/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 02/13/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 02/13/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 10/18/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 10/13/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/30/2016 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought 28,518 shares
@ $4.54, valued at
$129.5k
Bought 15,100 shares
@ $4.6, valued at
$69.5k
|
|
| 09/21/2016 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought 5,580 shares
@ $4.76, valued at
$26.6k
Bought 41,259 shares
@ $4.77, valued at
$196.8k
|
|
| 09/20/2016 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought 15,880 shares
@ $4.76, valued at
$75.6k
Bought 36,632 shares
@ $4.78, valued at
$175.1k
|
|
| 09/07/2016 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought 16,977 shares
@ $4.78, valued at
$81.2k
|
|
| 08/29/2016 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought 55,224 shares
@ $4.57, valued at
$252.4k
|
|
| 08/25/2016 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought 9,599 shares
@ $4.36, valued at
$41.9k
Bought 57,772 shares
@ $4.55, valued at
$262.9k
|
|
| 08/23/2016 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought 53,524 shares
@ $4.23, valued at
$226.4k
Bought 21,950 shares
@ $4.26, valued at
$93.5k
|
|
| 08/18/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 08/04/2016 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought 2,363,636 shares
@ $0
Bought 1,772,727 options to buy
@ $5.5, valued at
$9.7M
|
|
| 07/12/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 07/01/2016 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought 2,678,301 shares
@ $0
Bought 2,008,726 options to buy
@ $5.35, valued at
$10.7M
|
|
| 05/27/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 03/22/2016 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
| 03/16/2016 |
4
| Pharmstandard International S.A. (10% Owner) has filed a Form 4 on ARGOS THERAPEUTICS INC|
Txns:
| Bought 1,785,534 shares
@ $0
Bought 1,339,151 options to buy
@ $5.35, valued at
$7.2M
|
|